Panamor 50 Mg Dispersible Tablet 50 mg DISPERSIBLE TABLET
PDF Leaflet Revision Date: 24 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of acute gout attacks.
Dosage (summary)
Adults: 100-150 mg daily in divided doses; max 150 mg for 3 days.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy (20 weeks+) and lactation.
Key Drug Interactions
- Methotrexate
- Lithium
- Diuretics
- Anticoagulants
Contraindications
- Hypersensitivity to diclofenac
- Active gastrointestinal ulcer
- Heart failure
- Pregnancy
- Porphyria
Common side effects
- Gastrointestinal bleeding
- Headache
- Dizziness
- Rash
Counselling Points
- Take on an empty stomach
- Monitor for gastrointestinal symptoms
- Avoid in pregnancy and breastfeeding
Serious warnings
- Increased risk of cardiovascular events
- Gastrointestinal perforation
- Anaphylactic reactions
Important Disclaimer
The Panamor 50 Mg Dispersible Tablet 50 mg DISPERSIBLE TABLET professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
